Merck KGaA (OTCMKTS:MKKGY) Short Interest Update

Merck KGaA (OTCMKTS:MKKGYGet Free Report) was the recipient of a large increase in short interest in November. As of November 15th, there was short interest totalling 56,900 shares, an increase of 341.1% from the October 31st total of 12,900 shares. Based on an average daily volume of 154,600 shares, the days-to-cover ratio is presently 0.4 days.

Analysts Set New Price Targets

Separately, The Goldman Sachs Group assumed coverage on Merck KGaA in a research report on Thursday, September 19th. They issued a “buy” rating on the stock.

Check Out Our Latest Research Report on Merck KGaA

Merck KGaA Stock Up 0.6 %

MKKGY stock traded up $0.18 during midday trading on Wednesday, hitting $29.86. The company’s stock had a trading volume of 80,110 shares, compared to its average volume of 69,244. The company has a market cap of $19.30 billion, a PE ratio of 18.43, a P/E/G ratio of 2.32 and a beta of 0.96. Merck KGaA has a 12 month low of $28.96 and a 12 month high of $39.17. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The firm’s 50-day moving average is $33.21 and its 200-day moving average is $34.93.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Recommended Stories

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.